UK robotics start-up CMR Surgical has raised $600m in what it says was a record private financing round for a medical technology company, pushing its total funds raised above $1bn and giving it a $3bn valuation.
The Series D financing was led by SoftBank Vision Fund 2, the Japanese conglomerate’s second big venture capital vehicle, to which it has allocated $30bn.
CMR will use the investment for global commercialisation of its first product, Versius, which was launched in 2019 and provides surgeons with multiple robotic arms to perform a wide range of keyhole operations.
您已閱讀18%（575字），剩餘82%（2547字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。